Biochemical Changes in Liver Associated with
Kwashiorkor
Helen B. Burch, … , Fernando Viteri, Nevin S. Scrimshaw
J Clin Invest.
1957;
36(11)
:1579-1587.
https://doi.org/10.1172/JCI103556
.
Research Article
Find the latest version:
BIOCHEMICAL CHANGES IN LIVER ASSOCIATED WITH
KWASHIORKOR1
By HELEN B. BURCH,2 GUILLERMO
ARROYAVE,3
RUTHSCHWARTZ,4
ANA MARIA PADILLA,3 MOISflS BflHAR,3 FERNANDO VITERI,S ANDNEVIN S. SCRIMSHAW3
(From the Department of Pharmacology, Washington University SchoolofMedicine,St. Louis, Missouri, and theInstituteofNutritionofCentral Americaand Panama (INCAP),
Guatemala City, Guatemela)
(Submitted for publication June 10,
1957;
accepted July18, 1957)
Kwashiorkor,
the most prevalent form of
se-vere
protein
malnutrition,
is a serious
disease,
often
fatal to young children and
especially
commonfrom weaning to five years of age. There are
in-sufficient
data
concerning the chemical
changes
which take place
during
development
of
the
dis-ease, although clinical information is extensive.
Present knowledge about various aspects of the
disease has been reviewed
by Trowell, Davies,
andDean
(1),
by Brock
(2,
3)
and more
recently by
Scrimshaw
and co-workers
(4).
Its biochemical
characteristics include low levels of
serumpro-tein, amylase,
alkaline
phosphatase,
pseudo-cholin-esterase,
cholesterol, riboflavin
and vitamin
A.Concomitantly
the livers
areusually
found
to behigh
in fat and low in protein.
Waterlow
(5, 6)
did
pioneering
work
onen-zymes in liver
biopsy specimens
from
malnour-ished children and reported that hepatic
lactic
dehydrogenase
and
cytochrome oxidase
of four
children in
Gambia
remained
virtually unchanged
after
treatment
whereas pseudo-cholinesterase
was
initially
low but
morethan
doubled
ontreat-ment.
Later, Waterlow and Patrick
(7, 8)
stud-ied
levels
of eight
enzymes in liver
biopsy samples
from a
large
number of
malnourished children in
IThis investigation was supported in part by the
Na-tional Science Foundation, The Williams-Waterman Fund for the Combat of Dietary Diseases, the Nutrition Foundation, Inc., and National Institute of Arthritis and Metabolic Diseases of the National Institutes of Health (A-981), Public Health Service. Reported in part at
the annual meeting of the American Societyof Biological Chemists, April, 1957. INCAP Scientific Publication I-86.
2Pan
American Sanitary Bureau Consultantto INCAP from July28 to September9, 1956.S Staff members of the Institute of Nutrition of Cen-tral America and Panama (INCAP).
4Fellow of the World Health Organization of the United Nations.
Jamaica
onadmission
tothe hospital and after
treatment.
For
cytochrome
oxidase,
lactic,
malic
and
glutamic
dehydrogenases,
succinoxidase,
DPNH-cytochrome C
reductase and transaminase
they
reportunchanged activity following
treat-ment.The only
enzymefound
tobe reduced in
activity in the disease
wasnon-specific
cholinester-ase,
which increased
on treatment.Extensive dietary studies in various
partsof
the world where children suffer from kwashiorkor
reveal
inadequate intake of protein
aswell
aslow
dietary
levels of other essential nutrients
(1,
3).
The protein is often of
poorquality and therefore
unfavorable for the synthesis of tissue protein. If
dietary situations exist such that protein
andother
nutrients
necessaryfor the synthesis of
hepatic
enzymes are
inadequate, the levels of
some en-zymesin the liver should reflect the lack.
Certain
hepatic
flavin
enzymes,particularly
xanthine oxidase (9, 10), D-amino acid oxidase
(11,
12), and glycolic acid oxidase (12),
aregreatly
decreased either by riboflavin, protein
orcaloric deficiency in
rats.Xanthine oxidase is
also lowered by the lack of a single essential amino
acid
in the diet (13, 14). The levels of these
flavo-proteins and of riboflavin might conceivably
be
related to some of the changes in metabolism
which
occurin the livers of children with
diseases
of
malnutrition,
particularly where dietary
pro-tein and riboflavin are low.
This report gives results of biochemical
meas-urements
onliver biopsy samples from Guatemalan
children with
kwashiorkor. Analyses
were made
for xanthine, D-amino, acid, and glycolic acid
oxi-dases,
DPNH-dehydrogenase,
malic
dehydroge-nase,
transaminase,
riboflavin, total oxidized
pyr-idine nucleotides, cholesterol, lipid and protein
in the liver as well as the
protein, cholinesterase
and amylase in
serumand riboflavin in red blood
H. B. BURCH ET AL.
cells.
Samples
were obtained from 13children,
in six
casesboth before
andafter
treatment.For
comparison, levels in liver specimens
atau-topsy from North
Americanchildren
dying of
causes unrelated
to kwashiorkor were alsomeas-ured.
To
assesspossible
postmortemeffects the
livers of normal
rats wereassayed at
various
in-tervals after
death.EXPERIMENTAL METHODS
Sampling procedures. The children were selected as cases of typical kwashiorkor on admission to the
Gen-eral Hospital or the Hospital of the "Sociedad
Protec-tora del Nifio" of Guatemala City. If the prothrombin time ofa blood sample proved satisfactory the initial
bi-opsy sample was taken before any feeding or treatment
was given. Franseen needle biopsies were done by
as-piration through the pleural space after local anesthesia with procaine. The sample was put at once into an
ice-cold tube which remained in ice until brought to the laboratory 30 to45 minutes later.
The biopsy sample was rapidly weighed and dropped
into a small glass homogenizer, containing 15 to 20
vol-umes of 0.02 M nicotinamide at 4° C., and thoroughly homogenized. Nicotinamidewasusedtoprevent splitting of DPN by tissue DPNase. If the sample was large enough, about 5 mg. were taken for histological study. Eachsample weighed 20 mg.ontheaverage andprovided enough tissue forthe 12analyses in duplicateortriplicate. Initial biopsy samples were obtained from 10 children. Fromsixof these, biopsy samples werealsoobtained after
three to four weeks of treatment. At this time the chil-drenweregaining weight andtypicalclinical signs ofthe disease such as edema, diarrhea, and skin lesions had disappeared. Although accurate dietary control was not
possible to achieve in the wardsof the General Hospital, the children usually received a mixed diet which included
milk and supplementary vitamins. Adequate supervision ofthediet waspossible atthe Hospital of the "Sociedad Protectora del Nifto" where two children, M.A. and S.R., stayed. They received a diet rich in protein, par-ticularlymilkprotein, eating gradually increasing amounts upto5 grams of protein and 150 calories per kilo per day. Noliver samples from well-nourished Guatemalan chil-dren with no history of kwashiorkor were available for determinations of normal liver levels of chemical
sub-stances. However, to add to the group of recovered cases, biopsy samples were analyzed from three children clinically recovered from kwashiorkor, S.R., T.A. and I.T., from whom no initial samples were obtained. An-other approximation of normal hepatic levels was
ob-tained
from liver at autopsy of childrendying
of causes unrelatedtokwashiorkor in theSt. Louis Children's Hos-pital. To determinepossible
consequences of postmortem delay, livers from a series of rats wereanalyzed
at in-tervalsof0,
1,6 and 10 hours after deathfromablow onthehead. The deadrats wereallowedtoremain at room
temperature during the specified time intervals.
Analytical procedures. Labile enzymes were measured as soon as possible after sampling. DPNH-dehydroge-nase was determined within 30 minutes after samples arrivedin the laboratory. A spectrophotometric method
was used which involved measurement of the change in optical density of DPNH at 350 my with potassium ferricyanide as the electron acceptor (12). D-amino acid and glycolic acid oxidases were measured by the method of Burch, Lowry, Combs, and Padilla (15) scaledto the useof 0.25 mg. of tissue (30
id.
incubation volumes). These methods depend upon the spectro-photometric measurement of the 3-hydrazinoquinoline derivatives of the a-keto acids formed during the action of the enzymes on D-alanineorglycolicacid, respectively, during a 30-minute incubation period. Xanthine oxidasewas measured by the rate of oxidation of 2-amino4-hydroxypteridine to fluorescent isoxanthopterin in the
presence of 5 X 10' M methylene blue (12). This method completely avoids the usual troubles from tissue blanks.
Asa rule, 10
pl.
of 1: 20 homogenate, or0.5 mg. of liverwereusedfor eachanalysis. Riboflavin coenzymes, flavin
mononucleotide (FMN) and flavin adenine dinucleotide (FAD) were determined on the first few biopsy samples andthe autopsy samples byapublished fluorometric pro-cedure (16). On later biopsy samples only the total riboflavin was measured. Oxidized pyridine nucleotides (PN) were determined after trichloroacetic acid pre-cipitation of protein by a fluorometric procedure of Lowry, Roberts, and Kapphahn (17). Protein was de-termined calorimetrically (18).
The more stable enzymes and other substances were measured on frozen aliquots of the homogenates. For malic dehydrogenase (MDH) and aspartic-glutamic transaminase, methods developed for brain enzymes (19, 20) were adapted to liver samples. MDH was allowed
to reduce oxalacetate with DPNH, and the DPN + formed was measured byits fluorescence in alkaline solu-tion. Transaminase was allowed to act on a-keto gluta-rate and aspartate in the presence of DPNH and an
ex-cess of purified pig heart MDH. The oxalacetate pro-duced immediately oxidized DPNH to DPN+ which
was measured fluorometrically. For each determination
of MDH 0.15 y of human liver or 0.08
'y
of rat liverwere incubated in a
12-/Al.
volume, and for each deter-mination oftransaminase
5 y of human or rat liver were incubated in50.1d.
Cholesterol in 0.5-mg. liver samples was estimated by
thefluorometric method of Albers and Lowry (21) modi-fied by McDougal and Farmer (22) for serum. Good reproducibility and 98 to 100 per cent recovery of added cholesterol were obtained. Lipids were measured on samples of similar size. Extraction was accomplished with 3:1 alcohol-ether mixture by adding 10 volumes for
each of three extractions. The solvents were evaporated
in awater bathat 90° C. and finally the last traces were removedin a special vacuum desiccator (21). The resi-due was extracted with ether; the ether was evaporated
TABLE I
Hepaticriboflavinandflavinenzymes inkwashiorkor, initially(I)and after treatment(T)*
Total Xanthine D-amino Glycolic
DPNH-riboflavin oxidase acidoxidase acid oxidase dehydrogenase
Sex and Time mg./Kg., mM/Kg.,!hr. mM/Kg.,/hr. mM/Kg./hr. M/Kg.-/hr.
age Clinical treated
Case yrs. severity days I T I T. I T I T I T
P. G.f F-2.0 sev. 4 26 0.0 55 71 4.2
R.Ot M-5.5 mod. 10 137 1.7 134 473 17.5
M. J. F-3.0 mod. 12 138 1.6 78 20.1
L.A. F-7.0 mod. 17 108 3.5 147 362 16.3
Z. A. F-3.8 mod. 26 123 109 1.5 7.9 114 581 485 527 20.2 15.5
M. A. M-4.0 mod. 48 155 109 4.0 5.2 168 552 500 524 24.2 15.4
R. V. F-1.8 mod. 28 142 99 3.1 7.6 218 444 764 456 12.7 15.5
M.C. F-1.7 mod. 29 92 122 2.7 5.4 179 430 342 509 15.0 14.4
L. S. F-4.0 sev. 29 113 106 3.9 6.4 216 218 506 221 19.6 12.6
L. C. F-3.0 sev. 26 103 115 1.2 5.2 96 421 333 516 21.0 17.2
S. R. M-1.5 mod. 60 138 10.5 433 639 17.6
T.A. M-1.5 mod. 168 113 8.0 407 575 14.5
I. T. M-3.3 sev. 71 103 5.6 402 587 15.6
Mean 123 113 2.6 6.9 150 432 471 506 18.5 15.4
S.E. 7 4 0.4 0.6 16 34 52 42 1.2 0.5
*ValuesexpressedperKg.ofliver protein.
tThese twochildrendiedinthehospital. Valuesfor P.G.weremuch lowerthanallothers and have been excluded
fromtheaverages.
off and the lipid determined by the colorimetric method
of Bragdon (23) adapted for 8 to 100 pug. of lipid in a
final volume of 0.4 ml. by Chiang, Gessert, and Lowry
(24). Trimyristin (Distillation Products Industries)
was used as the standard lipid. Quantitative recovery
of added lipid and reproducibility were obtained in pre-liminarytests madewith ratandhuman liver.
In serum, protein was measured by the gradient tube method of Lowry and Hunter (25), cholinesterase and amylase by methods of Reinhold, Tourigny, and Yonan
(26) and Smith and Roe (27). Red blood cell ribo-flavin on packed red cells was measured by a previously published method (28).
RESULTS
A.
Clinical findings
Four
of the children had severe kwashiorkor and
the
remainder were cases of moderate
severity.
All
showed typical
hair changes, skin lesions and
edema. Apathy
was a
general
characteristic,
and
all
had diarrhea.
Child
P.G. was
diagnosed
ini-tially
as
having
very
severe
and
apparently
ir-reversible
kwashiorkor and died four days after
entering
the
hospital.
B.
Hepatic
fiavin
enzymes
All enzyme and coenzyme values have been
cal-culated on
the
basis of protein. The data on
ribo-flavin
and four flavin enzymes (Table I) obtained
on
six children from whom biopsy samples were
taken
initially
and
after treatment
revealed
no
significant
rise in
riboflavin, glycolic
acid oxidase
or
DPNH-dehydrogenase.
Remarkable increases
are
apparent in
xanthine oxidase and D-amino
acid
oxidases.
These
findings
are of
special
in-terest
since,
in
the rat,
hepatic
xanthine oxidase
falls
with low dietary levels either of
protein,
calo-ries or
riboflavin, whereas DPNH-deyhdrogenase
does
notchange
in
caloric restriction
orriboflavin
deficiency (12)
until animals
are neardeath.
D-amino acid and
glycolic acid oxidases
in rat liver
also fall if
dietary
riboflavin is absent but
arenot
so
greatly affected
by
low
protein
or
calories
asxanthine
oxidase.
Therefore,
D-amino acid
oxi-dase may not
respond
in
the same manner to
die-tary restrictions in children with kwashiorkor
asit
does in rats.
Unusually
low levels
wereobtained
onchild
P.G. who
failed
to
respond
to treatment.
Pos-sibly the
very
low
levels of these enzymes and
other
substances
were
associated with irreversible
changes
in the
liver.
The liver
sample
of P.G.
was more
fatty
in gross appearance
than
any other.
The DPNH-dehydrogenase
is
particularly
inter-esting
asit is
the only
really
low
value found
for
H. B. BURCH ET AL.
The values in Table I indicate
ahighly
signifi-cant
increase in hepatic
xte andD-amino
acid oxidase levels calculated
on thebasis
of liverprotein of eight children
before and after treat-mentof kwashiorkor.
The othet
'enzymes givenin Tables I and II did
notincreake
significantly
relative
toliver protein.
C.
Hepatic
substances other thanflavin
enzymesLiver protein (Table II)
increased onan-aver-age
of
38
per cent(p
<0.01) during
treatment-in the six
individuals studied
both before andafter
therapy.
At the same time totallipid
fell to lessthan one-third
the initialvalue,
whereascholesterolin
the few samples tested showed
nosignificant
change.
Two
non-flavin enzymes,transaminase,
and
malicdehydrogenase,
chosen fortheir
sig-nificance
inrelation
toamino acid
metabolism and
the citric
acidcycle, respectively,
weremeasuredascontrols of the flavin
enzymes.Neither
enzymewas
changed significantly
inthe liver
after treatment.Pyridine nucleotides (DPN and TPN)
appear, toincrease inmostcasesupontreatmentalthough
the
increase is notstatistically significant.
Thesenucleotides
aredestroyed
withexceptional speed
by tissue
and red cell enzymesandmayhave been
partially split
in somesamples before
analysis
waspossible. A
change in
extentof oxidation
of thesecoenzymes would
also
affect the results. In ratliver samples,
adecrease in total oxidized
pyri-dine nucleotides PN occurred
whenthey
werekept in
an icebath
at40
C. for
one hour withoutnicotinamide and analyzed by the technique
usedon
the
biopsy samples (Table IV).
Therefore,
the levelsreported hereare
possibly
somewhat -lowbut
should be comparable
before and aftertreat-ment
since the specimens
weresimilarly
handled,
and
enzymeaction
wasstopped by adding aliquots
to
trichloroacetic acid
atonce.D. Protein and
enzymesinserumA
significant increase (p
<0.01) in
serumpro-tein
on treatment(Table III)
wasaccompanied
by
asignificant rise (p
<0.01)
inserumcholines-terase relative to
protein.
The increase in serumamylase
wasnotsignificant.
Ifactivities
of theseenzymes are
calculated
per unitvolume
thein-crease
become three-fold
for cholinesterase andtwo-and-one-half-fold for amylase.
Thusthey
would
appear tohave
decreasedsimilarly
inkwashiorkor and
tobe
synthesized
atapproxi-mately the
same rateupon recoveryfrom the
dis-ease.It
isobvious
fromthe
data, however,
thatthe
two enzymes behavedifferently
relative toserum
protein.
EII
Lwerconcentrationsofcertainsubstancesin
kwaskiorkor,
initially (I)andafter treatment (T)*Protein Lipid Cholesterol Malic. dehyd. Transaminase OxidizedPN
Gm./Kg.. Gw./Kg, Gm./Kgv. M/Kg./hr. M/Kg./hr. mM/Kg.
Case I T I T I T I T I T I T
P.G.t 31 19 29 0.7
R. O. 108 995 89 85 3.8
M. J. 167 102 91
L. A. 141 107 64 2.8
Z.A. 124 150 257 23 101 132 96 76 2.8 5.9
M.A. 106 199 805 24 121 90 91 so 4.5 3.4
R.V. 87 192 833 250 28 25 176 113 91 60 3.4 4.1
M.C. 133 169 737 190 30 15 108 81 64 60 3.0 3.6
L.S. 121 167 731 219 15 24 122 105 84 56 4.1 4.6
L.C. 147 186 -115 106 69 83 3.0 4.3
S.R. 144 360 26 124 118 5.3
T.A. 172 194 16 102 66 4.1
I.T. 191 199 18 100 70 3.8
Mean 126 174 820 238 24 21 116 106 82 71 3.4 4.4
S.E. 8 6 47 19 2 2 8 6 4 7 0.3 0.3
*Protein per Kg.of wettissue; others expressed per Kg. of liver protein.
TABLE III
Laeds
of
fourconstitens
of
bood serm
orcels
inkwaskierkor
and theefeds
oftreatment
Seam Serum
Serum cholliesterase amylase Redcell
protein unils/Gm. SuikRoeunilu/ riboflavin
Gn./1(00 d. AProw$* G.mroku ,.g./100Mi.
Case I T I T I T I T
P.G. 3.45t 275t 1.7t 24.2t
R. O. 3.77 250 13.3 10.5
L.A. 4.60 335 3.0 14.7
Z. A. 4.10 6.68 330 540 8.3 11.1 11.2 18.6
M.A. 4.36 6.91 235 890 .85.0t
7.5t
10.9 19.2R. V. 4.50 7.68 455 935 2.9 15.0 11.0
M.C. 3.50 6.00 270 550 3.1 8.0 23.8 27.8
L. S. 3.90 6.42 400 610 20.0 12.4 24.0 39.0
L. C. 3.74 7.48 515 660 8.3 11.4 13.9 24.2
S.R. 23.2
T. A. 6.40 820 4.5
I.T. 6.75 715 14.8 26.2
Mean 4.06 6.79 3501 715§ 8.41
11.0§
15.0 25.4S.E. 0.14 0.20 30 55 2.3 1.5 2.0 2.3
* Theunit activityof theoriginalserum asdefined byReinhold, Tourigny, and Yonan (26) multipliedby 5,000
and divided by Gm. protein per 100 ml.
t
Omittedfrom the averageasinprevious
tables.*
ChildM. A.had hypertrophiedsalivary glands. Thesevalues havenotbeen included in theaverage.I
Theaverage serum cholinesterase expressedasMichelUnits is 0.28 1: 0.03 initiallyand0.98:1: 0.09after treat-ment; theserum amylase expressedasSmith-RoeUnits per 100 ml. is 33 4 9and 76 F11,respectively.Comparison
of
the increases
in
serumprotein
and
cholinesterase with that
of liver
protein (Table
II)
suggests
that
serum
cholinesterase
and
serumprotein
regenerate
simultaneously
with
liver
pro-tein
during
recovery.
The reports of Waterlow
and others
(1)
that
cholinesterase
and
protein
in
both liver
and
plasma
arelow
in kwashiorkor and
increase
greatly
on treatment
arein
accord
with
these results. The data
on serumamylase
aretoovariable
toindicate any
significant
relation
toprotein
in
liver.
Red blood cell
riboflavin increased 70
per
cent ontreatment
although the
liver riboflavin
failed
to
show such a
change.
Few data
areavailable
for red
cell
riboflavin levels
in young
children, but
for four
children of similar
ages
anaverage of
30
y
per 100 ml.
waspreviously reported (29).
In
adults, Bessey,
Horwitt,
and Love
(30)
have
found
the red cell
level to be
areliable criterion
of
riboflavin
deficiency, although
in rats,
atleast,
the liver is
a moresensitive index of mild
defi-ciency
(31). Since there
was noother
evidence
of riboflavin
deficiency,
the
changes
may
be
sec-ondary
toother alterations
in
the red cells.
E. Liver
specimens
at autopsy
Since
information similar to
that obtained from
livers of children with kwashiorkor was not
avail-able for
those
of normal young children,
measure-ments
were made on liver specimens from St.
Louis
autopsies.
Samples from
five
children who
seemed to be
well-nourished and who died after
periods
of one to four days in the hospital were
analyzed.
The
time before
samples were
available
varied from two to six hours after death. Levels
obtained
on
the
liver
autopsy
samples (Table IV)
are in
most instances similar to those obtained on
liver biopsy samples of the cases of kwashiorkor
after treatment.
However, xanthine oxidase and
glycolic acid oxidase activities averaged distinctly
higher in the autopsy samples (100 and
50
per
cent,
respectively). The
average
xanthine oxidase
value is five times greater than for the untreated
children with
kwashiorkor.
Since glycolic
acid
oxidase
in
kwashiorkor
did not
change
appreci-ably as the result of treatment, the low values
among
the
children concerned may reflect some
deficiency
or
disease state other
than kwashiorkor.
For
example,
this
enzyme is
asensitive
index
of
H. B. BURCH ET AL.
unU)'0-4N0
C14 v-4 00
v-'-4 eq*
bew~4o.4cUo
44.4CVek)0% % NO '0M 4)
.00 0N- 0
0-toC)Av40 00
#-S. U)kNx )
¢Ebe m
> eu
S
Pe
S OX
be+_b
_be
tOU) eq (4a U No -4
00
WI) TV)
k-U) N
u cm
.- .
eqP
t-4J
A
o b%
0
o-o
a.- co 00
co X_ee
0
0
N04
I
-N00)01100N M 00 t~- co %O
t'-Nt'.
cU~oNMNOl+N
_%4t. m c4 c ONd
oo 00 t0 U)c
in - >m Cbs
_ o_ et
11)
0 c 00 00 00
* 00U)Oo
~.
M*--- >
,;:Od
04=
^4~
14c
IsU)
o64 M M M M M
1584
?I%
*e
I&
lb va
l4b
II
I.,.
00
4
,>
Cd
oq
'1'
IC
0
The rat
liver analyses
(Table IV)
are
pre-sented as a confirmation of
the
validity
of analyses
on autopsy
material.
None of the four enzymes
tested were
diminished
significantly within
six
hours of the death of
the
rat,
and
only
one,
DPNH-dehydrogenase,
was
changed
within 10 hours. The
coenzymes are not so
stable;
10 to 15 per cent
FAD was converted to
FMN
in 6 to 10
hours,
and
pyridine
nucleotides
were
either
hydrolyzed
or reduced
by
40 per
centin 10 hours.
Human
liver may not split FAD as rapidly as rat
liver,
however,
since FMN
was
only 10 per cent of FAD
in spite of the time lag before
obtaining
speci-mens.
It will be noted
that
total riboflavin and
all four
flavin
enzymes
arehigher
in
ratliver
than
in
human
liver,
although transaminase is only
slightly
higher
in
the rat.
DISCUSSION
Values for liver and
serumenzyme activities
have been
expressed
throughout
on
the
basis of
protein
because
of the well
known
changes
in
liver
and serum
protein concentrations during
treatment
of kwashiorkor.
Hepatic
flavin
enzymes
The
flavin
enzymes, xanthine and D-amino
acid
oxidase,
which were found to be low in
kwashior-kor
have
also been
shown
to
be
lowered in rat
liver
by
either
protein
orriboflavin deficiency.
Al-though glycolic
acid oxidase is
greatly diminished
in rat
liver
by
riboflavin
deficiency, it
remains
un-changed
in human liver with treatment of
kwashi-orkor.
DPNH-dehydrogenase,
however, is not altered
in
either
the liver
of children
with
kwashiorkor
or
in
the tissues of rats
during riboflavin deficiency
or
caloric
restriction.
Wainio
and
co-workers
(32)
report that
DPNH-cytochrome C reductase
falls in
protein deficiency
in
the
rat,
but
this
has
not been confirmed in
this
laboratory
(12).
Its
failure to fall in
these livers,
except in
the
child
P.G. who died,
supports
the idea that this
is one
of the most crucial of known
flavin
enzymes and
one
of
those
most
firmly held
by liver tissue even
in various deficiency states.
This
seeming
paradox of finding no fall in
ribo-flavin,
relative to protein in liver from kwashiorkor
cases
when
some
flavin
enzymes have dropped, is
resolved
by
the
fact that these enzymes account
for
an
exceedingly small
fraction
-of
the total flavin
present
in liver.
Other
substances in the liver
It is of interest that cholesterol does not
in-crease
in
the liver in kwashiorkor according to
the values presented here. This is contrary to the
few data available on cases of kwashiorkor from
India
(33) in which much higher initial levels
were
found and a decrease
with treatment was
noted.
The
finding of virtually unchanged levels of
hepatic malic dehydrogenase and transaminase
activity
upon treatment
of
kwashiorkor
agrees
with
Waterlow and Patrick
(7). However, the
abso-lute activity found by these investigators for
trans-aminase is
only one-fifteenth of the
level reported
here.
This discrepancy may be traced to
differ-ences in
methods used. These workers also
found
rat
liver to be seven
times
lower in
transaminase
activity
than human liver.
In
the method used
here,
oxalacetate produced is immediately reduced
to
malate,
which prevents approach to
equilibrium
and consequent
slowing
of
the
reaction. Without
means for removing one of the products, larger
samples
as may
have been used by Waterlow
and
Patrick
(7)
in
their studies of rat liver would
give
lower
relative values.
It is now possible to measure a large number of
enzymes with
relative
ease in
the
amount of
ma-terial
obtained
by
liver
needle
biopsy
specimens.
Through study
of
alterations
in the enzymes, a
better
understanding
of
the
metabolic
changes
in
diseased tissues may be achieved.
Changes
in
these
functional
proteins
are
particularly
relevant
to a
deficiency
disease such
askwashiorkor.
SUMMARY
1. Chemical
changes in liver and serum
during
treatment
of
13 children with kwashiorkor
arereported.
Results
of similar
analyses
on
liver
au-topsy
specimens
from
five
St. Louis children
dying
from causes unrelated to kwashiorkor are also
in-cluded, together
with
analyses
of livers
from
12
rats, to confirm the validity of studying autopsy
material.
Concomit-H. B. BURCH ET AL.
antly there
were
striking
increases relative
topro-tein in xanthine oxidase and
D-aminoacid oxidase.
3.
During treatment of the children with
kwashi-orkor
nosignificant changes
relative toprotein
were
found in the
following
substances in liver:
riboflavin, glycolic acid oxidase,
DPNH-dehy-drogenase,
malic
dehydrogenase,
trannase,
oxidized
pyridine
nucleotides,
and cholesterol.
4.
The
levels of all substances measured in
thelivers of kwashiorkor cases after
treatment weregenerally equal
to those
of autopsy
specimens
ofSt.
Louischildren,
except
forglycolic
acid oxidaseand xanthine oxidase which did
not increase tothe
values
found in the autopsy
samples.
5. Protein in serum increased 70 per
centduring
treatment and relative
toprotein,
cholinesteraseincreased
100 per
centand
amylase
30 per
cent.The red blood
cell riboflavin
doubled.
ACKNOWLEDGMENTS
The autopsy specimens were made available through
thediligent efforts ofDr.Donald B.Strominger, towhom
the authors are greatly indebted. The authors wish to
express their appreciation to Dr. Oliver H. Lowry for
his exceedinglyhelpful advice andencouragement during
this study. They also gratefully acknowledge the as-sistance of Miss Laura Herradora and Mrs. Loty de Funes in the analyses on serum.
REFERENCES
1. Trowell, H. C., Davies, J. N. P., andDean, R. F.A.,
Kwashiorkor. London, EdwardArnold Ltd., 1954. 2. Brock,J. F., Surveyof the worldsituationon
kwashi-orkor in Conference on Nutritional Factors and Liver Diseases,Annals of the New York Academy
of Sciences. New York, New York Academy of Sciences, 1954,vol. 57,p. 696.
3. Brock, J. F., Nutrition in Annual Review of
Bio-chemistry. Stanford, Annual Reviews, 1955, vol. 24, p. 523.
4. Scrimshaw,N.S.,Behar, M.,Arroyave,G., Viteri, F.,
and Tejada, C., Characteristics of kwashiorkor (Sindrome pluricarencial delainfancia).
Federa-tionProc., 1956, 15, 977.
5. Waterlow,J. C., Observations ontheactivity of some enzymes in the human liver. West Indian M. J.,
1951, 1, 41.
6. Waterlow, J. C., Enzyme activity in human liver in
Liver Injury, Transactions of the Eleventh
Con-ference, F. W. Hoffbauer, Ed. New York, Josiah
MacyJr. Foundation, 1953, p. 72.
7. Waterlow, J. C., and Patrick, S. J., Enzyme activity in fatty livers in human infants in Conference on
Nutritional Factors and Liver Diseases, Annals of
the New York Academy of Sciences. New York, New YorkAcademy of Sciences, 1954, vol.
57,
p. 750.8. Protein Malnutrition; Proceedings of a conference in Jamaica (1953) sponsored jointly by the Food and Agriculture Organization of the United Na-tions, the World Health Organization and the Josiah Macy Jr. Foundation, J. C. Waterlow, Ed. Cambridge, Cambridge Univ. Press, 1955, p. 16. 9. Axelrod, A. E., and Elvehjem, C. A., The xanine
oxidasecontentof ratliver in riboflavindeficiency. J. Biol. Chem., 1941, 140, 725.
10. Richert, D. A., and Westerfeld, W. W., Some
inter-relations of dietary protein,molybdenum, riboflavin
and calories on liver and intestinal xanthine oxi-dase. Proc. Soc. Exper. Biol. & Med., 1953, 83,
726.
11. Axelrod, A. E., Sober, H. A., and Elvehjem, C. A., The D-amino acid oxidase content of rat tissues
in riboflavin deficiency. J. Biol. Chem., 1940, 134, 749.
12. Burch, H. B., Lowry, 0. H., Padilla, A. M., and
Combs, A. M., Effects of riboflavin deficiency and
realimentation on flavin enzymes of tissues. J. Biol. Chem., 1956, 223, 29.
13. Williams,J.N.,Jr.,andElvehjem, C. A., Therelation of amino acid availability in dietary protein to liver enzyme activity. J. Biol. Chem., 1949, 181,
559.
14. Williams, J. N., Jr., andElvehjem, C. A., The effects of tryptophan deficiency upon enzyme activity in the rat. J. Biol. Chem., 1950, 183, 539.
15. Burch, H. B., Lowry, 0. H., Combs, A. M., and
Padilla, A. M., A sensitive methodfor measuring
amino acid oxidases. Apr., 1956, Abstracts, Div. of Biol. Chem., Am. Chem. Soc., 129th meeting, Dallas.
16. Burch,H. B., Fluorimetricassayof FAD, FMN,and
riboflavin inMethods in Enzymology, S. P.
Colo-wick and N. 0. Kaplan, Eds. New York, Aca-demic Press Inc., 1957,vol. III, p. 960.
17. Lowry, 0. H., Roberts, N. R., and Kapphahn, J. I., The fluorometric measurement of pyridine nucleo-tides. J. Biol. Chem., 1957, 224, 1047.
18. Lowry, 0. H., Rosebrough, N. J., Farr, A. L., and
Randall,R.J., Protein measurement with the Folin
phenol reagent. J. Biol. Chem., 1951, 193, 265. 19. Lowry, 0. H., Roberts, N. R., and Lewis, C., The
quantitative histochemistry of the retina. J. Biol.
Chem., 1956, 220, 879.
20. Lowry, 0. H., Roberts, N. R., andChang, M. L. W.,
Theanalysis of single cells. J. Biol. Chem., 1956,
222, 97.
21. Albers, R. W., and Lowry, 0. H., Fluorometric de-terminationof 0.1 to 10 micrograms ofcholesterol. Anal. Chem., 1955, 27, 1829.
22. McDougal, D. B., Jr., and Farmer, H. S., A fluoro-metric methodfor total serum cholesterol. J. Lab. & Clin. Med., 1957, 50, 485.
23. Bragdon, J. H., Colorimetric determinatonof blood bhatll d itre i ,a qantities of blood lipids. J. BioL Chem, 1951, 10, 513. serumandcelils. J,- Biol. Chem., 1948, 175, 457. 24. Chiang, S. P., Gessert, C. F., and Lowry, 0. H., 29.
Snyderman,
S. E., Retron, K. C., Burch, H. B.,Personal
ommunication.
Lowry,
0.-H7Bems_,
9.-A.Guy,
LXP., andHolt, 25. Lowry, 0. H., and Hunter, T.H.,Thedeterminatier L E.,jr
e minimum riboflavin requirement ofof serum proteinconcentration with a gradient tube. theinfant. Nutrition, 1949, 39, 219.
J. Biol. Chem., 1945, 159, 465.i30.BeseT, 0. A., Horwltt M. -E and Love, R H., 26. Reinhold, J. G., Tourigny, L. G., and Ynain, V.-L., Dietary deprivation of riboflavin and blood ribo-Measurementof serumcholinesterase activity by a flavin levels in man. J. Nutrition, 1956, 58, 367. photometric indicator methoc Tb' eer with a 31.
Lo*y,
O. H.,-Bioddkhical evidence of nutritional study of the influence of sex and race. Am. J. status. Physiol. Rev., 1952, 32, 431.Clin.
Path.,
1953,- 23 645. 32.;Wainio,
W. W.,BEicel,-B.,
Ziche, H.J.,
Person, P., 27. Smith, B. W., and Roe,J.-H., A photometric method Istes, F. Lo.*nd
l J B 0xidatve enzymes for the determination ofB-ainylase
in blood and oftheliver inprotein
3ionJ.
Nuttion,
1953, urine, with use df thestarch-iodine
color. J. Biol. 49,46S.
Chem.,-1949, 179, 53. 33.